Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine-induced killer cell transfusion

Liver International

Volumn 29, Issue 3, 2009, Pages 466-474

  Shi, Ming ^a   Fu, Junliang ^a   Shi, Feng ^a   Zhang, Bin ^a   Tang, Zirong ^a   Zhang, Zheng ^a   Zhang, Hui ^a   Jin, Lei ^a   Chen, Liming ^a   Wang, Huifeng ^a   Akbar, Sheikh Mohammad Fazle ^b   Wang, Fu Sheng ^a  

^a BEIJING 302 HOSPITAL   (China)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adoptive therapy; Chronic hepatitis B; Cytokine induced killer cells; Hepatitis B virus; Myeloid dendritic cells; Plasma cytoid dendritic cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CYTOKINE; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 12; VIRUS DNA;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHENIA; CELL SUBPOPULATION; CELL TRANSFER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INSOMNIA; KILLER CELL; MALE; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LOAD;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CYTOKINE-INDUCED KILLER CELLS; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 59849117144     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01861.x     Document Type: Article

References (35)

1. Niederau K, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon-alpha for chronic hepatitis B. N Engl J Med 1996; 334: 1422-7.
2. Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-56.
3. Sun J, Gao Y, Chen HS, et al. Transfusion of multi-factors activated immune cells as a novel treatment for patients with chronic hepatitis B. J Clin Virol 2006; 35: 26-32.
4. Wang FS, Liu MX, Zhang B, et al. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo. World J Gastroenterol 2002; 8: 464-8.
5. Shi M, Zhang B, Tang ZR, et al. Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. World J Gastroenterol 2004; 10: 1146-51.
6. Reignat S, Webster GJ, Brown D, et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 2002; 195: 1089-101.
7. Cella M, Facchetti F, Lanzavecchia A, Colonna A. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000; 1: 305-10.
8. Liu YJ. IPC: Professional Type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275-306.
9. Van der Molen RG, Sprengers D, Binda RS, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004; 40: 738-46.
10. Beckebaum S, Cicinnati VR, Dworacki G, et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002; 104: 138-50.
11. Beckebaum S, Cicinnati VR, Zhang X, et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: Mechanisms for viral immune escape. Immunology 2003; 109: 487-95.
12. Akbar SM, Horiike N, Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J Gastroenterol 2006; 12: 2876-83.
13. Tavakoli S, Mederacke I, Herzog-Hauff S, et al. Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 2008; 151: 61-70.
14. van der Molen RG, Sprengers D, Biesta PJ, Kusters JG, Janssen HLA. Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV. Hepatology 2006; 44: 907-14.
15. Zhang Z, Chen D, Yao J, et al. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B. Clin Immunol 2007; 122: 173-80.
16. + killer cells. Blood 1995; 86: 3493-9.
17. Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells. J Immunol 2000; 164: 5998-6004.
18. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002; 32: 1958-68.
19. Ilan Y, Nagler A, Adler R, Tur-kaspa R, Slavin S, Shouval D. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology 1993; 104: 1818-21.
20. Lau GK, Suri D, Liang R, et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002; 122: 614-24.
21. Couillin I, Pol S, Mancini M, et al. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens. J Infect Dis 1999; 180: 15-26.
22. Lindemann M, Barsegian V, Runde V, et al. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. Transplantation 2003; 75: 833-8.
23. Michel ML, Pol S, Brechot C, Tiollais P. Immunotherapy of chronic hepatitis B by anti HBV vaccine: From present to future. Vaccine 2001, 19: 2395-9.
24. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
25. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
26. Tsubouchi E, Akbar SM, Horiike N, Onji M. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol 2004; 39: 754-62.
27. Untergasser A, Zedler U, Langenkamp A, et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006; 43: 539-47.
28. Chen LE, Zhang Z, Chen WW, et al. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 2007; 178: 6634-41.
29. Arima S, Akbar SM, Michitaka K, et al. Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 2003; 11: 169-74.
30. Shi M, Qian S, Chen WW, et al. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 2007; 147: 277-86.
31. Zhang Z, Zhang H, Chen D, et al. Response to interferon-alpha treatment correlates with recovery of blood plasmacytoid dendritic cells in children with chronic hepatitis B. J Hepatol 2007; 47: 751-9.
32. Li L, Liu D, Hutt-Fletcher L, Morgan A, Masucci MG, Levitsky V. Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 2002; 99: 3725-34.
33. Varani S, Cederarv M, Feld S, et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol 2007; 179: 7767-76.
34. Kim HM, Lim J, Yoon YD, et al. Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma. Int Immunopharmacol 2007; 7: 1793-801.
35. Dauer M, Schad K, Junkmann J, et al. IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4. J Leukoc Biol 2006; 80: 278-86.